These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 3005987)

  • 1. ApaI RFLP 5.4 kb 5' to the human apolipoprotein AI (APO A1) gene.
    Frossard PM; Coleman R; Funke H; Assman G
    Nucleic Acids Res; 1986 Feb; 14(4):1922. PubMed ID: 3005987
    [No Abstract]   [Full Text] [Related]  

  • 2. DNA polymorphic sites in the human ApoAI-CIII-AIV cluster: Taq I and Ava I.
    Cohen T; Karathanasis SK; Kazazian HH; Antonarakis SE
    Nucleic Acids Res; 1986 Feb; 14(4):1924. PubMed ID: 3005989
    [No Abstract]   [Full Text] [Related]  

  • 3. BanI dimorphic site in the third intron of the human apolipoprotein AI gene (Apo A1).
    Frossard PM; Coleman RT; Lim DW
    Nucleic Acids Res; 1987 Jan; 15(1):381. PubMed ID: 2881258
    [No Abstract]   [Full Text] [Related]  

  • 4. A study of DNA polymorphisms around the human apolipoprotein AI gene in hyperlipidaemic and normal individuals.
    Kessling AM; Horsthemke B; Humphries SE
    Clin Genet; 1985 Oct; 28(4):296-306. PubMed ID: 2998654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and DNA sequence of full-length cDNA and of the entire gene for human apolipoprotein AI--discovery of a new genetic polymorphism in the apo AI gene.
    Seilhamer JJ; Protter AA; Frossard P; Levy-Wilson B
    DNA; 1984 Aug; 3(4):309-17. PubMed ID: 6207999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms in the apolipoprotein AI-CIII gene complex.
    Coleman RT; Gonzalez PA; Funke H; Assmann G; Levy-Wilson B; Frossard PM
    Mol Biol Med; 1986 Jun; 3(3):213-28. PubMed ID: 3016454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [DNA restriction fragment length polymorphism (RFLP) of insulin and apolipoprotein A-I (apo A-I) genes in patients with diabetes mellitus coexistent with polyendocrinopathy].
    Grzywa M; Buraczyńska M; Tatoń J; Matwiszyn B
    Pol Tyg Lek; 1987 Dec; 42(50):1598-601. PubMed ID: 2898774
    [No Abstract]   [Full Text] [Related]  

  • 8. Confirmation of the close linkage between the loci for human apolipoproteins AI and AIV by the use of a cloned cDNA probe and two restriction site polymorphisms.
    Rogne S; Myklebost O; Olaisen B; Gedde-Dahl T; Prydz H
    Hum Genet; 1986 Jan; 72(1):68-71. PubMed ID: 3002953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A BanII dimorphic site located in the third intron of the human apolipoprotein AI (APOA1) gene.
    Coleman RT; Kresnak MT; Frossard PM
    Nucleic Acids Res; 1988 Feb; 16(3):1221. PubMed ID: 2894007
    [No Abstract]   [Full Text] [Related]  

  • 10. Deletion polymorphism 5' to the human apolipoprotein AI (apo AI) gene.
    Frossard PM; Coleman RT; Protter AA; Seilhamer JJ; Funke H; Assmann G
    Nucleic Acids Res; 1986 Nov; 14(21):8694. PubMed ID: 3097620
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of genetic variation at the apo AI-CIII-AIV gene cluster in determining plasma apo AI levels in boys and girls.
    Xu CF; Angelico F; Del Ben M; Humphries S
    Genet Epidemiol; 1993; 10(2):113-22. PubMed ID: 8339925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic relationship between equine apolipoproteins A4 and A1.
    Kakoi H; Gawahara H
    Anim Genet; 1997 Aug; 28(4):306-7. PubMed ID: 9345728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial combined hyperlipidaemia linked to the apolipoprotein AI-CII-AIV gene cluster on chromosome 11q23-q24.
    Wojciechowski AP; Farrall M; Cullen P; Wilson TM; Bayliss JD; Farren B; Griffin BA; Caslake MJ; Packard CJ; Shepherd J
    Nature; 1991 Jan; 349(6305):161-4. PubMed ID: 1670899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA polymorphisms flanking the apo A-1 and insulin genes and type III hyperlipidaemia.
    Vella M; Kessling A; Jowett N; Rees A; Stocks J; Wallis S; Galton D
    Hum Genet; 1985; 69(3):275-6. PubMed ID: 2984107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of a PstI polymorphism of the apolipoprotein-AI gene in Australian patients with coronary artery disease.
    Dorow DS; Burke J; Goding JW
    Aust N Z J Med; 1989 Dec; 19(6):677-81. PubMed ID: 2517191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Polymorphism of the apolipoprotein A-I gene and susceptibility to non-insulin-dependent diabetes mellitus].
    Buraczyńska M; Hanzlik J; Grzywa M
    Pol Tyg Lek; 1987 Dec; 42(50):1602-5. PubMed ID: 3452804
    [No Abstract]   [Full Text] [Related]  

  • 17. Genetic polymorphisms and atherosclerosis.
    Galton DJ
    Monogr Atheroscler; 1986; 14():113-8. PubMed ID: 3090427
    [No Abstract]   [Full Text] [Related]  

  • 18. The two apolipoprotein loci apo A-I and apo A-IV are closely linked in man.
    Schamaun O; Olaisen B; Mevåg B; Gedde-Dahl T; Ehnholm C; Teisberg P
    Hum Genet; 1984; 68(2):181-4. PubMed ID: 6500569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NcoI dimorphic site located 8kb 3' to the human apolipoprotein AIV (APOA4) gene.
    Coleman RT; Malloy MJ; Kane JP; Frossard PM
    Nucleic Acids Res; 1988 Feb; 16(3):1222. PubMed ID: 2894008
    [No Abstract]   [Full Text] [Related]  

  • 20. Apolipoprotein AI-CIII gene polymorphisms in Japanese myocardial infarction survivors.
    Satoh J; Hattori N; Onuki M; Yamakawa K; Fujiwara H; Amamiya H; Nagaoka H; Sakuma T; Yamanouchi Y; Okafuji T
    Jinrui Idengaku Zasshi; 1987 Mar; 32(1):15-20. PubMed ID: 2886684
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.